Solution for injection - 0.5 mg / 1 ml
Prozerine contains neostigmine metilsulfate as active substance, which inhibits cholinesterase activity and thus prolongs and intensifies the physiological actions of acetylcholine. Prozerine is indicated:
- in the treatment of Myasthenia gravis;
- as antidote to the non-depolarising neuromuscular blockers;
- in the treatment of paralytic ileus and postoperative urinary retention.
Solution for injection - (0.1%) 1 mg/1 ml
Sugar-coated tablets – 10 mg
Film-coated tablets – 600 mg
Solution for injection - (0.1%) 1 mg/1 ml
Tablets - 25 mg
